Sign In
Buy NVUS
$3.52
+0 (+0%)
At Close: Aug 17, 2022
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
11:06am, Wednesday, 16'th Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 15) Celgene Corporation (NASDAQ: CELG ) Eagle Pharmace
Do Institutions Own Shares In Novus Therapeutics, Inc. (NASDAQ:NVUS)?
12:07pm, Wednesday, 09'th Oct 2019
If you want to know who really controls Novus Therapeutics, Inc. (NASDAQ:NVUS), then you'll have to look at the makeup...
Novus Therapeutics to Participate in Two Upcoming Investor Conferences
12:30pm, Thursday, 29'th Aug 2019
Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will
Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market
10:00am, Monday, 22'nd Jul 2019
Adynxx, Inc. (ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflam
Investors Who Bought Novus Therapeutics (NASDAQ:NVUS) Shares A Year Ago Are Now Down 86%
02:28pm, Thursday, 11'th Jul 2019
It's not a secret that every investor will make bad investments, from time to time. But it's not unreasonable to try...
